Affinity DataKi: 0.00500nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.0130nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.0150nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.0150nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.0150nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.0180nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.0220nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.0610nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.0750nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.100nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.120nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.120nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.140nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.140nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.180nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.190nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.260nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.770nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 0.970nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 2.20E+3nMAssay Description:Displacement of [3H]R1881 from full length androgen receptor in human LNCAP cellsMore data for this Ligand-Target Pair
Affinity DataKi: 3.35E+3nMAssay Description:Displacement of [125I]somatostatin from human SSTR2 expressed in CHO-K1 cell membranes after 240 minsMore data for this Ligand-Target Pair
Affinity DataKi: 5.00E+3nMAssay Description:Binding affinity to rat androgen receptor ligand binding domain by fluorescence polarization assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.110nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Orchid Pharma
Curated by ChEMBL
Orchid Pharma
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human PDE4B using [3H]cAMP as substrate incubated for 5 mins followed by substrate addition and measured after 10 mins by scintillation...More data for this Ligand-Target Pair
Affinity DataIC50: 0.400nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Affinity DataIC50: 0.400nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Affinity DataIC50: 0.5nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of human Nampt after 3 hrs by counting analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 0.5nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of Nampt (unknown origin) using nicotinamide as substrate preincubated for 15 mins measured after 30 mins by mass spectrometry analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 0.600nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Affinity DataIC50: 0.800nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of C-terminal His-tagged NAMPT (unknown origin) expressed in Escherichia coli BL21 using nicotinamide as substrate preincubated for 15 min...More data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of C-terminal His-tagged NAMPT (unknown origin) expressed in Escherichia coli BL21 using nicotinamide as substrate preincubated for 15 min...More data for this Ligand-Target Pair
Affinity DataIC50: 1.10nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Affinity DataIC50: 1.40nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.70nMAssay Description:Inhibition of Nampt (unknown origin) using nicotinamide as substrate preincubated for 15 mins measured after 30 mins by mass spectrometry analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 1.80nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 1.90nMAssay Description:Inhibition of Nampt (unknown origin) using nicotinamide as substrate preincubated for 15 mins measured after 30 mins by mass spectrometry analysisMore data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of C-terminal His-tagged NAMPT (unknown origin) expressed in Escherichia coli BL21 using nicotinamide as substrate preincubated for 15 min...More data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of Nampt (unknown origin) using NAM/PRPP as substrate preincubated for 15 mins measured after 30 minsMore data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of Nampt (unknown origin) using nicotinamide as substrate preincubated for 15 mins measured after 30 mins by mass spectrometry analysisMore data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of C-terminal His-tagged NAMPT (unknown origin) expressed in Escherichia coli BL21 using nicotinamide as substrate preincubated for 15 min...More data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of C-terminal His-tagged NAMPT (unknown origin) expressed in Escherichia coli BL21 using nicotinamide as substrate preincubated for 15 min...More data for this Ligand-Target Pair
Affinity DataIC50: 2.10nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
TargetNicotinamide phosphoribosyltransferase(Homo sapiens (Human))
Forma Therapeutics
Curated by ChEMBL
Forma Therapeutics
Curated by ChEMBL
Affinity DataIC50: 2.20nMAssay Description:Inhibition of Nampt (unknown origin) using nicotinamide as substrate preincubated for 15 mins measured after 30 mins by mass spectrometry analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 2.30nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair
Affinity DataIC50: 2.30nMAssay Description:Inhibition of Nav1.7 (unknown origin) expressed in HEK293 cells assessed as reduction in veratridine-induced depolarization preincubated for 15 to 20...More data for this Ligand-Target Pair